Corcept Therapeutics, Inc. (CORT)
40.83
+2.47
(+6.44%)
USD |
NASDAQ |
Feb 06, 16:00
41.15
+0.32
(+0.78%)
After-Hours: 20:00
Corcept Therapeutics SG&A Expense (TTM) : 401.86M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Axsome Therapeutics, Inc. | 514.57M |
| Johnson & Johnson | 23.68B |
| United Therapeutics Corp. | 627.50M |
| Harrow, Inc. | 144.39M |
| Ultragenyx Pharmaceutical, Inc. | 343.56M |